ArticlePloS one2025
Association between body mass index and long-term all-cause mortality in critically ill patients without malignant tumors.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe "obesity paradox" in certain diseases has been reported in previous studies. This study aimed to investigate the relationship between BMI and long-term mortality in all critically ill patients without malignant tumors who were admitted to the ICU.
methodsUsing the MIMIC-IV 2.2 database, we included all ICU admissions for patients without malignant tumors and categorized them into four groups based on the World Health Organization (WHO) obesity criteria. The relationship between BMI and 90-day, 180-day, and 1-year mortality was analyzed using univariate and multivariate Cox regression models, along with restricted cubic spline (RCS) models to account for potential non-linear associations.
resultsA total of 19,089 patients were included, with 90-day, 180-day, and 1-year mortality rates of 18.35%, 20.80%, and 23.96%, respectively. Overweight and obese patients exhibited significantly lower mortality rates compared to underweight and normal-weight individuals at all time points. After adjusting for confounders, higher BMI remained a protective factor for long-term mortality (HR 0.65-0.72, P < 0.001). RCS curves demonstrated a U-shaped relationship between BMI and mortality, and subgroup analyses confirmed the protective effect of higher BMI in different subgroups.
conclusionThe "obesity paradox" may apply to critically ill patients without malignant tumors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.